🟢 Tiziana Life Sciences is trading 5.7% up in after-hours trading after BTIG initiated coverage with a Buy rating

Tiziana Life Sciences is trading at $1.03 (+5.70%) in after-hours trading after BTIG initiated coverage with a Buy rating and a $7.00 price target.

• Coverage began September 3, 2026.
• BTIG highlighted intranasal foralumab and upcoming INFORM-MS data as major potential catalysts.
• The broader risk-on market may provide additional support, with the Nasdaq up 1.64% during regular trading.